Zaoqu Liu

6.1k citations

142 papers · 3.4k indexed · 5 hit papers · h-index 32

Impact in

Cancer Research top 1%
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
Oncology top 2%
- Cancer Immunotherapy and Biomarkers

Papers in ⓘ

Oncology 63
- Cancer Immunotherapy and Biomarkers 43
Pulmonary and Respiratory Medicine 61
- Ferroptosis and cancer prognosis 47

Co-authors: Xinwei Han (59 shared papers)Quan Cheng (61 shared papers)Peng Luo (68 shared papers)Libo Wang (28 shared papers)Long Liu (36 shared papers)Jian Zhang (51 shared papers)Siyuan Weng (39 shared papers)Yuyuan Zhang (33 shared papers)
Journals: Frontiers in Immunology (18 papers)Frontiers in Cell and Developmental Biology (7 papers)Molecular Cancer (6 papers)Frontiers in Oncology (6 papers)International Immunopharmacology (3 papers)
Partner nations: China United Kingdom United States

In The Last Decade

Zaoqu Liu

137 papers receiving 3.4k citations

Hit Papers

5 papers align trajectories log scale

Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets 2025 · 77 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2025 Signal Transduction and Targeted Therapy
2024 Signal Transduction and Targeted Therapy
2023 Molecular Cancer
2022 Journal of Hematology & Oncology
2022 Nature Communications

Peers

Countries citing papers authored by Zaoqu Liu

Since Specialization

Citations

This map shows the geographic impact of Zaoqu Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zaoqu Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zaoqu Liu more than expected).

Fields of papers citing papers by Zaoqu Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zaoqu Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zaoqu Liu. The network helps show where Zaoqu Liu may publish in the future.

Co-authors

The 25 scholars most cited alongside Zaoqu Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Zaoqu Liu Line = papers co-authored together Zaoqu Liu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 142 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer Nature Communications ·Zaoqu Liu, Long Liu, Siyuan Weng, Chunguang Guo, Qin Dang, Hui Xu, Libo Wang, Taoyuan Lu, Yuyuan Zhang, Zhenqiang Sun, Xinwei Han Hit paper breakdown →	2022	455
2	Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials Molecular Cancer ·Hao Zhang, Xinghai Yue, Zhe Chen, Chao Liu, Wantao Wu, Nan Zhang, Zaoqu Liu, Liping Yang, Qing Jiang, Quan Cheng, Peng Luo, Guodong Liu Hit paper breakdown →	2023	228
3	Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts Journal of Hematology & Oncology ·Yuchen Wang, Hao Zhang, Chao Liu, Zeyu Wang, Wantao Wu, Nan Zhang, Longbo Zhang, Jason J. Hu, Peng Luo, Jian Zhang, Zaoqu Liu, Yun Peng, Zhixiong Liu, Lanhua Tang, Quan Cheng Hit paper breakdown →	2022	174
4	Ferroptosis: a double-edged sword mediating immune tolerance of cancer Cell Death and Disease ·Qin Dang, Ziqi Sun, Yang Wang, Libo Wang, Zaoqu Liu, Xinwei Han	2022	95
5	Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment Molecular Cancer ·Zhifei Gao, Yifeng Bai, Anqi Lin, Aimin Jiang, Chaozheng Zhou, Quan Cheng, Zaoqu Liu, Xin Chen, Jian Zhang, Peng Luo	2023	90
6	Machine learning-based identification of tumor-infiltrating immune cell-associated lncRNAs for improving outcomes and immunotherapy responses in patients with low-grade glioma Theranostics ·Nan Zhang, Hao Zhang, Wantao Wu, Ran Zhou, Shuyu Li, Zeyu Wang, Ziyu Dai, Liyang Zhang, Fangkun Liu, Zaoqu Liu, Jian Zhang, Peng Luo, Zhixiong Liu, Quan Cheng	2022	89
7	CAMOIP: a web server for comprehensive analysis on multi-omics of immunotherapy in pan-cancer Briefings in Bioinformatics ·Anqi Lin, Chang Qi, Ting Wei, Mengyao Li, Quan Cheng, Zaoqu Liu, Peng Luo, Jian Zhang	2022	88
8	Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets Signal Transduction and Targeted Therapy ·Fan Guan, Ruixuan Wang, Zhenjie Yi, Peng Luo, Wanyao Liu, Yao Xie, Zaoqu Liu, Zhiwei Xia, Hao Zhang, Quan Cheng Hit paper breakdown →	2025	77
9	A novel immune classification reveals distinct immune escape mechanism and genomic alterations: implications for immunotherapy in hepatocellular carcinoma Journal of Translational Medicine ·Zaoqu Liu, Yuyuan Zhang, Chengcheng Shi, Xueliang Zhou, Kaihao Xu, Dechao Jiao, Zhenqiang Sun, Xinwei Han	2021	76
10	Machine learning-based tumor-infiltrating immune cell-associated lncRNAs for predicting prognosis and immunotherapy response in patients with glioblastoma Briefings in Bioinformatics ·Hao Zhang, Nan Zhang, Wantao Wu, Ran Zhou, Shuyu Li, Zeyu Wang, Ziyu Dai, Liyang Zhang, Zaoqu Liu, Jian Zhang, Peng Luo, Zhixiong Liu, Quan Cheng	2022	66
11	Comprehensive machine-learning survival framework develops a consensus model in large-scale multicenter cohorts for pancreatic cancer eLife ·Libo Wang, Zaoqu Liu, Ruopeng Liang, Weijie Wang, Rongtao Zhu, Jian Li, Zhe Xing, Siyuan Weng, Xinwei Han, Yuling Sun	2022	61
12	A New Trend in Cancer Treatment: The Combination of Epigenetics and Immunotherapy Frontiers in Immunology ·Zaoqu Liu, Yuqing Ren, Siyuan Weng, Hui Xu, Lifeng Li, Xinwei Han	2022	57
13	Multi-stage mechanisms of tumor metastasis and therapeutic strategies Signal Transduction and Targeted Therapy ·Zaoqu Liu, Jingqi Chen, Yuqing Ren, Shutong Liu, Yuhao Ba, Anning Zuo, Peng Luo, Quan Cheng, Hui Xu, Xinwei Han Hit paper breakdown →	2024	54
14	Radiogenomics: a key component of precision cancer medicine British Journal of Cancer ·Zaoqu Liu, Tian Duan, Yuyuan Zhang, Siyuan Weng, Hui Xu, Yuqing Ren, Zhenyu Zhang, Xinwei Han	2023	50
15	The Identification and Validation of Two Heterogenous Subtypes and a Risk Signature Based on Ferroptosis in Hepatocellular Carcinoma Frontiers in Oncology ·Zaoqu Liu, Libo Wang, Long Liu, Taoyuan Lu, Dechao Jiao, Yuling Sun, Xinwei Han	2021	49
16	The role of DNA damage repair (DDR) system in response to immune checkpoint inhibitor (ICI) therapy Journal of Experimental & Clinical Cancer Research ·Congqi Shi, Kaiyu Qin, Anqi Lin, Aimin Jiang, Quan Cheng, Zaoqu Liu, Jian Zhang, Peng Luo	2022	48
17	TTN/OBSCN ‘Double‐Hit’ predicts favourable prognosis, ‘immune‐hot’ subtype and potentially better immunotherapeutic efficacy in colorectal cancer Journal of Cellular and Molecular Medicine ·Zaoqu Liu, Libo Wang, Chunguang Guo, Long Liu, Dechao Jiao, Zhenqiang Sun, Kunpeng Wu, Yanan Zhao, Xinwei Han	2021	45
18	Tumor buster - where will the CAR-T cell therapy ‘missile’ go? Molecular Cancer ·Chunrun Qu, Hao Zhang, Hui Cao, Lanhua Tang, Haoyang Mo, Fangkun Liu, Liyang Zhang, Zhenjie Yi, Lifu Long, Luzhe Yan, Zeyu Wang, Nan Zhang, Peng Luo, Jian Zhang, Zaoqu Liu, Weijie Ye, Zhixiong Liu, Quan Cheng	2022	44
19	Clinical Significance and Inflammatory Landscape of aNovel Recurrence-Associated Immune Signature in Stage II/III Colorectal Cancer Frontiers in Immunology ·Zaoqu Liu, Taoyuan Lu, Jing Li, Libo Wang, Kaihao Xu, Qin Dang, Long Liu, Chunguang Guo, Dechao Jiao, Zhenqiang Sun, Xinwei Han	2021	43
20	Exosome-based nanoimmunotherapy targeting TAMs, a promising strategy for glioma Cell Death and Disease ·Hong Luo, Hao Zhang, Jinning Mao, Hui Cao, Yihao Tao, Guanjian Zhao, Zhiwen Zhang, Nan Zhang, Zaoqu Liu, Jian Zhang, Peng Luo, Yuguo Xia, Yuan Cheng, Zongyi Xie, Quan Cheng, Guodong Liu	2023	40

About Zaoqu Liu

Zaoqu Liu is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Immunology, having authored 142 papers that have together received 3.4k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (47 papers), Cancer Immunotherapy and Biomarkers (43 papers), Immune cells in cancer (23 papers), Cancer-related molecular mechanisms research (17 papers), Immune Cell Function and Interaction (15 papers), Cancer Genomics and Diagnostics (13 papers), MicroRNA in disease regulation (12 papers) and RNA modifications and cancer (11 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (1.2k citations), Immunology (826 citations), Pulmonary and Respiratory Medicine (1.2k citations) and Molecular Biology (1.5k citations). Zaoqu Liu has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Xinwei Han, Quan Cheng, Peng Luo, Libo Wang, Long Liu, Jian Zhang, Siyuan Weng, Yuyuan Zhang, Qin Dang and Chunguang Guo. Their work appears in journals such as Frontiers in Immunology, Frontiers in Cell and Developmental Biology, Molecular Cancer, Frontiers in Oncology and International Immunopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact